A comparison of striatal and mesolimbic dopamine function in the rat during 6-month trifluoperazine administration

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Psychopharmacology

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1007/BF00433087PMID 6774362
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• EFFECT OF CHLORPROMAZINE OR HALOPERIDOL ON FORMATION OF 3METHOXYTYRAMINE AND NORMETANEPHRINE IN MOUSE BRAIN.

  2009cited by this paper
• Neuroleptic-induced hypersensitivity of striatal dopamine receptors in the rat as a model of tardive dyskinesias. Effects of clozapine, haloperidol, loxapine and chlorpromazine

  2004cited by this paper
• Changes in rat striatal dopamine turnover and receptor activity during one years neuroleptic administration.

  1980cited by this paper
• Striatal dopamine receptors become supersensitive while rats are given trifluoperazine for six months

  1979cited by this paper
• Changes in dopamine-mediated behaviour during one year's neuroleptic administration.

  1979cited by this paper
• Induction of dopaminergic mesolimbic receptor supersensitivity by haloperidol.

  1978cited by this paper
• Dopamine binding following prolonged haloperidol pretreament

  1978cited by this paper
• Spiperone: a ligand of choice for neuroleptic receptors. 1. Kinetics and characteristics of in vitro binding.

  1978cited by this paper
• Different dopamine stimulation of adenylate cyclase in striatum and mesolimbic area of rats treated with chronic chlorpromazine.

  1978cited by this paper
• Does dopamine play a role in schizophrenia?

  1977cited by this paper
• Differential regional development of tolerance to increase in dopamine turnover upon repeated neuroleptic administration.

  1977cited by this paper
• Dopaminergic supersensitivity in striatum and olfactory tubercle following chronic administration of haloperidol or clozapine.

  1977cited by this paper
• A serotonergic component of neuroleptic receptors.

  1977cited by this paper
• Brain neurotransmitter receptors after long-term haloperidol: dopamine, acetylcholine, serotonin, alpha-noradrenergic and naloxone receptors.

  1977cited by this paper
• The nucleus accumbens–possible site of antipsychotic action of neuroleptic drugs?

  1977cited by this paper
• Stereotyped behaviour patterns and hyperactivity induced by amphetamine and apomorphine after discrete 6-hydroxydopamine lesions of extrapyramidal and mesolimbic nuclei.

  1977cited by this paper
• Clozapine: reduction of the initial dopamine turnover increase by repeated treatment.

  1976cited by this paper
• The effect of long-term penfluridol treatment on the sensitivity of the dopamine receptors in the nucleus accumbens and in the corpus striatum

  1975cited by this paper
• The Action of Neuroleptic Drugs on Dopamine-Stimulated Adenosine Cyclic 3',5'-Monophosphate Production in Rat Neostriatum and Limbic Forebrain

  1974cited by this paper
• Tolerance phenomena with neuroleptics catalepsy, apomorphine stereotypies and striatal dopamine metabolism in the rat after single and repeated administration of loxapine and haloperidol.

  1973cited by this paper
• The pharmacology of tardive dyskinesias.

  1973cited by this paper
• The significance of dopamine-receptor blockade for the mechanism of action of neuroleptic drugs.

  1966cited by this paper
• The significance of dopamine-receptor blockade for the mechanism of action of neuroleptic drugs.

  1966cited by this paper
• IS IT POSSIBLE TO PREDICT THE CLINICAL EFFECTS OF NEUROLEPTIC DRUGS (MAJOR TRANQUILLIZERS) FROM ANIMAL DATA?I. "NEUROLEPTIC ACTIVITY SPECTRA" FOR RATS.

  1965cited by this paper

• Perinatal Treatments with the Dopamine D2-Receptor Agonist Quinpirole Produces Permanent D2-Receptor Supersensitization: a Model of Schizophrenia

  2015cites this paper
• Mesolimbic dopamine function is not altered during continuous chronic treatment of rats with typical or atypical neuroleptic drugs

  2005cites this paper
• Chronic treatments with zotepine, thioridazine, and haloperidol affect apomorphine-elicited stereotypic behavior and striatal 3H-spiroperidol binding sites in the rat

  2004cites this paper
• Effects of discontinuous drug administration on the development of dopamine receptor supersensitivity during chronic trifluoperazine or cis-flupenthixol administration to rats

  2004cites this paper
• Proceedings of the British Pharmacological Society

  2004cites this paper
• Oral dyskinesia in rats following brain lesions and neuroleptic drug administration

  2004cites this paper
• Electron spin resonance spectroscopy reveals alpha‐phenyl‐N‐tert‐butylnitrone spin‐traps free radicals in rat striatum and prevents haloperidol‐induced vacuous chewing movements in the rat model of human tardive dyskinesia

  2004influential citation
• Differences in the time course of dopaminergic supersensitivity following chronic administration of haloperidol, molindone, or sulpiride

  2004cites this paper
• Behavioral Evidence of Depolarization Block of Dopamine Neurons after Chronic Treatment with Haloperidol and Clozapine

  2000cites this paper
• D3 Receptors and the Actions of Neuroleptics in the Ventral Striatopallidal System of Schizophrenics

  1999cites this paper
• Change in basal ganglia volume over 2 years in patients with schizophrenia: typical versus atypical neuroleptics.

  1999cites this paper
• Linking the Family of D2 Receptors to Neuronal Circuits in Human Brain: Insights into Schizophrenia

  1997cites this paper
• Persistent spontaneous oral dyskinesias in haloperidol-withdrawn rats neonatally lesioned with 6-hydroxydopamine: absence of an association with the Bmax for [3H]raclopride binding to neostriatal homogenates.

  1997cites this paper
• Autoradiographic mapping of μ opioid receptor changes in rat brain after long-term haloperidol treatment: relationship to the development of vacuous chewing movements

  1996cites this paper
• D1 and D2 receptor modulation in rat striatum and nucleus accumbens after subchronic and chronic haloperidol treatment.

  1992cites this paper
• The Dopamine Hypothesis and Neurophysiology Concepts in Schizophrenia

  1992cites this paper
• Estimation of haloperidol concentrations in rat striatum after chronic treatment.

  1991cites this paper
• The neuropathology of schizophrenia.

  1988cites this paper
• Differences in the time course of haloperidol-induced up-regulation of rat striatal and mesolimbic dopamine receptors.

  1988cites this paper
• Chronic pharmacological manipulation of dopamine receptors in brain.

  1987cites this paper
• The future of neuroleptic psychopharmacology.

  1986cites this paper
• Behavior of rats during one-year administration of fluphenazine and subsequent withdrawal period.

  1986cites this paper
• Problems in Classification of Schizophrenics as Neuroleptic Responders and Nonresponders

  1985cites this paper
• Interpretation of changes in apomorphine-induced stereotyped behaviour in rats receiving continuous administration of trifluorperazine for 15 months.

  1984cites this paper
• Dopamine and schizophrenia: an analysis of the theory.

  1984cites this paper
• Chronic administration of three neuroleptics: effects of behavioral supersensitivity mediated by two different brain regions in the rat.

  1983cites this paper
• Flupenthixol in depression. A study of serum levels and prolactin response.

  1983cites this paper
• The effect of chronic neuroleptic administration on cerebral dopamine receptor function.

  1983cites this paper
• Alterations in cerebral dopamine function caused by administration of cis- or trans-flupenthixol for up to 18 months.

  1983cites this paper
• A Model for Oral Dyskinesia in Rats

  1982cites this paper
• Increased striatal acetylcholine after 14 months cis-flupenthixol treatment in rats suggests functional supersensitivity of dopamine receptors.

  1982cites this paper
• Age affects dopamine receptor changes during chronic administration of fluphenazine.

  1982cites this paper
• Proceedings of the British Pharmacological Society. 16--18th December, 1980.

  1981cites this paper